6598 — Applied BioCode Share Price
0.000.00%
Last trade - 00:00- TWD2.27bn
- TWD1.76bn
- TWD395.17m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.94 | ||
| Price to Tang. Book | 3.96 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 5.45 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -23% | ||
| Return on Equity | -25.58% | ||
| Operating Margin | -45.5% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | TWDm | 104.69 | 299.01 | 319.96 | 390.3 | 395.17 | 430 | n/a | 60.67% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Applied BioCode Corp is engaged in the provision of digital biological barcode detection technology platforms and related products. The Company's products mainly include digital biological barcodes, optical analyzers, in vitro diagnostic reagents, and others. The Company sells products in the United States, Europe and Asian markets.
Directors
- Jia-Long Lee CHM
- Zohn-Zen Ho FDR
- Liang-Kai Huang CFO
- Michael Aye VPR
- Donald Wong VPR
- Youning Chen DGM
- Benjamin Jen DRC
- Jack Hsiao IND
- C.Y. Liu IND
- Wen-Jing Tsai IND
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- April 15th, 2016
- Public Since
- February 9th, 2017
- No. of Shareholders
- 17,519
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Taiwan Stock Exchange
- Shares in Issue
- 102,777,561
- Address
- 6F, No.1, Lane 28, TAIPEI, 114
- Web
- https://www.apbiocode.com/
- Phone
- +886 287916833
- Contact
- Zohn-Zen Ho
- Auditors
- PricewaterhouseCoopers
Upcoming Events for 6598
Similar to 6598
Abnova Taiwan
Taiwan Stock Exchange
Energenesis Biomedical Co
Taiwan Stock Exchange
Kim Forest Enterprise Co
Taiwan Stock Exchange
PHARMAESSENTIA
Taiwan Stock Exchange
Pell Bio Med Technology Co
Taiwan Stock Exchange
FAQ
What is the Applied BioCode share price?
As of Today at 19:17 UTC, shares in Applied BioCode are trading at TWD22.10. This share price information is delayed by 15 minutes.
How has the Applied BioCode share price performed this year?
Shares in Applied BioCode last closed at TWD22.10 and the price had moved by -2.23% over the past 365 days. In terms of relative price strength the Applied BioCode share price has underperformed the FTSE Developed Asia Pacific Index by -9.51% over the past year.
What are the analyst and broker recommendations for Applied BioCode?
The overall consensus recommendation for Applied BioCode is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Applied BioCode dividend yield?
Applied BioCode does not currently pay a dividend.
Does Applied BioCode pay a dividend?
Applied BioCode does not currently pay a dividend.
When does Applied BioCode next pay dividends?
Applied BioCode does not currently pay a dividend.
How do I buy Applied BioCode shares?
To buy shares in Applied BioCode you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Applied BioCode?
As of the previous close price of TWD22.10, shares in Applied BioCode had a market capitalisation of TWD2.27bn.
Where are Applied BioCode shares listed?
Here are the trading details for Applied BioCode:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 6598
What kind of share is Applied BioCode?
Based on an overall assessment of its quality, value and momentum Applied BioCode is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Applied BioCode share price forecast for 2024?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Applied BioCode share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Applied BioCode. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +5.72%.
As of the last closing price of TWD22.10, shares in Applied BioCode were trading -0.73% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Applied BioCode PE Ratio?
The Applied BioCode PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at TWD22.10.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Applied BioCode?
Applied BioCode's management team is headed by:
- Jia-Long Lee - CHM
- Zohn-Zen Ho - FDR
- Liang-Kai Huang - CFO
- Michael Aye - VPR
- Donald Wong - VPR
- Youning Chen - DGM
- Benjamin Jen - DRC
- Jack Hsiao - IND
- C.Y. Liu - IND
- Wen-Jing Tsai - IND